Prostatic Artery Embolization is Similarly Efficacious to Transurethral Resection of the Prostate (TURP) with a Better Safety Outcome: A Systematic Review and Meta-Analysis
Abstract
Benign prostatic hyperplasia (BPH) is a prevalent condition affecting over 50% of men aged 60 years and older, often leading to lower urinary tract symptoms (LUTS) that significantly reduce quality of life. Transurethral resection of the prostate (TURP) remains the standard treatment for moderate to severe BPH; however, it is associated with notable complications. Prostatic artery embolization (PAE) has emerged as a minimally invasive alternative with potential advantages in safety and recovery. This study aims to evaluate and compare the safety and efficacy of PAE and TURP in treating BPH, focusing on symptom improvement, prostate volume reduction, hospital stay duration, and adverse events. A systematic review and meta-analysis were conducted following PRISMA guidelines. Literature searches were performed in PubMed, the Cochrane Library, and ScienceDirect up to May 3, 2025. Studies comparing PAE and TURP reporting outcomes such as IPSS, prostate volume, length of stay, and adverse events were included. Data extraction and quality assessment were conducted using the RoB-2 tool, while statistical analysis was performed using Review Manager version 5.4. The findings revealed a non-significant trend favoring PAE in improving IPSS scores (mean difference -2.71, p=0.12) and reducing prostate volume (mean difference -9.62 mL, p=0.08). However, PAE significantly reduced hospital stay duration (mean difference -1.52 days, p<0.0001) and showed a lower risk of severe adverse events…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.